Price T Rowe Associates Inc Zoetis Inc. Transaction History
Price T Rowe Associates Inc
- $869 Billion
- Q3 2024
A detailed history of Price T Rowe Associates Inc transactions in Zoetis Inc. stock. As of the latest transaction made, Price T Rowe Associates Inc holds 4,126,021 shares of ZTS stock, worth $730 Million. This represents 0.09% of its overall portfolio holdings.
Number of Shares
4,126,021
Previous 4,793,925
13.93%
Holding current value
$730 Million
Previous $831 Million
3.0%
% of portfolio
0.09%
Previous 0.1%
Shares
16 transactions
Others Institutions Holding ZTS
# of Institutions
1,956Shares Held
412MCall Options Held
1.02MPut Options Held
1.09M-
Vanguard Group Inc Valley Forge, PA41.2MShares$7.3 Billion0.15% of portfolio
-
Black Rock Inc. New York, NY36.8MShares$6.52 Billion0.15% of portfolio
-
State Street Corp Boston, MA19.8MShares$3.5 Billion0.16% of portfolio
-
State Farm Mutual Automobile Insurance CO Bloomington, IL16MShares$2.84 Billion2.73% of portfolio
-
Alliancebernstein L.P. New York, NY15.4MShares$2.72 Billion1.05% of portfolio
About Zoetis Inc.
- Ticker ZTS
- Exchange NYSE
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 468,139,008
- Market Cap $82.8B
- Description
- Zoetis Inc. discovers, develops, manufactures, and commercializes animal health medicines, vaccines, and diagnostic products in the United States and internationally. It commercializes products primarily across species, including livestock, such as cattle, swine, poultry, fish, and sheep; and companion animals comprising dogs, cats, and horses. ...